Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialYung‐Jue Bang, Yoon‐Koo Kang, Eric Van Cutsem et al.|The Lancet|2010Cited by 7.3k
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upFlorian Lordick, Elizabeth Smyth, Fátima Carneiro et al.|Annals of Oncology|2022Cited by 1.4k
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal CancerTakashi Kojima, Manish A. Shah, Kei Muro et al.|Journal of Clinical Oncology|2020Cited by 1.2k
Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upFlorian Lordick, Dirk Arnold, C. Mariette et al.|Annals of Oncology|2016Cited by 1.1k